UK markets open in 4 hours 39 minutes

Novozymes A/S (0Q4U.IL)

IOB - IOB Delayed price. Currency in DKK
Add to watchlist
361.35-0.50 (-0.14%)
At close: 05:55PM GMT
Full screen
Previous close361.85
Bid0.00 x 0
Ask0.00 x 0
Day's range0.00 - 0.00
52-week range
Avg. volume214,426
Market cap101.095B
Beta (5Y monthly)0.40
PE ratio (TTM)27.40
EPS (TTM)13.19
Earnings dateN/A
Forward dividend & yield6.00 (1.66%)
Ex-dividend date03 Mar 2023
1y target est411.63
  • Globe Newswire

    Invitation to Novozymes' annual shareholders' meeting 2023

    To the shareholders of Novozymes A/S The Board of Directors is pleased to invite you to the company's annual shareholders' meeting on Thursday March 2, 2023 at 4:00 pm CET at Ballerup Super Arena Please read the invitation in PDF Til Novozymes A/S' aktionærer Betyrelsen har hermed fornøjelsen af at invitere dig til selskabets ordinære generalforsamling torsdag den 2. marts 2023 kl. 16.00 i Ballerup Super Arena Læs venligst den fulde invitation i PDF format Attachments Invitation to Novozymes' An

  • Globe Newswire

    Novozymes delivers historically strong full-year results

    Novozymes is delivering strong growth and earnings in a volatile market environment with 9% organic sales growth in 2022. This marks the highest organic sales growth in more than a decade, and Novozymes is confident about the 2023 outlook of 4-7%. COPENHAGEN, Denmark – January 26, 2026. In the 2022 financial year, Novozymes delivers 9% organic sales growth – 11% organic sales growth in the fourth quarter alone – an EBIT-margin before special items[*] of 26.4%, and ROIC including goodwill before